Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Ema    symbols : Nvsef    save search

Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published: 2023-05-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.0% C: -0.89%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.0% C: -1.2%

biosimilar authorization ema
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 3.12% H: 0.06% C: 0.06%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.31% C: 0.19%

fda biosimilar ema sclerosis multiple sclerosis
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Published: 2022-06-17 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.52% C: -3.23%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%

biosimilar ema application
Fluorine-18 Market to Exceed US$ 3 Bn by 2030; Surge in Use of PET/CT Scan in Oncology Spurs Demand for FDGs, Notes Study by TMR
Published: 2022-01-06 (Crawled : 15:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.82% C: 0.7%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.16% C: -0.45%
GE | $152.94 -1.75% 0.0% 6M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.91% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 0.0% C: 0.0%
LNTH | News | $62.34 1.4% 1.38% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.42% H: 2.7% C: 2.11%

ema scan
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Published: 2021-12-22 (Crawled : 07:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

ema application authorization biosimilar
Female Infertility Drugs Market to Grow by USD 538.69 mn | AbbVie Inc. and Aurobindo Pharma Ltd. Among Key Vendors | Technavio
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -0.56%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.5% C: -0.43%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%

ema drug pharma
BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
Published: 2021-12-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -4.23% H: 0.11% C: 0.11%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 2.02% H: 0.04% C: -0.89%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%
BSX | $67.42 -0.8% -0.53% 5.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.0% C: 0.0%
BDX | $233.15 0.41% 0.15% 890K twitter stocktwits trandingview |
Health Technology
| | O: 0.68% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.15% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%

ema diabetes
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%
INCY | $52.82 0.19% 0.19% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 0.0% C: 0.0%

ema car-t platform
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.